Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papillomavirus Type 18 Infection”

77 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 77 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04537156
What this trial is testing

Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerCondylomata Acuminata
Xiamen University 9,327
Not applicableLooking for participantsNCT05371353
What this trial is testing

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

Who this might be right for
HPV InfectionsCervical Cancer Stage IIaVaginal Cancer+4 more
Shanghai Bovax Biotechnology Co., Ltd. 600
Not applicableActive Not RecruitingNCT05669911
What this trial is testing

Development of a Self-collection Device for Cervical Cancer Screening

Who this might be right for
Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Human Papilloma Virus
Teal Health, Inc. 235
Testing effectiveness (Phase 2)Study completedNCT00339040
What this trial is testing

Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children

Who this might be right for
HIV InfectionsSexually Transmitted Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 130
Large-scale testing (Phase 3)Study completedNCT00929526
What this trial is testing

Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 752
Not applicableStudy completedNCT06919627
What this trial is testing

Negative HPV Test Results on Infinity/GeneXpert® With the Presence of a Late Amplification Signal: What Does This Mean ? (PaPCR)

Who this might be right for
Cervical CancersPapillomavirus InfectionsPapillomavirus Type 16/18 Infection
University Hospital, Brest 45
Large-scale testing (Phase 3)Study completedNCT00325130
What this trial is testing

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Who this might be right for
Neoplasms, Glandular and EpithelialDiphtheriaTetanus+2 more
Merck Sharp & Dohme LLC 1,042
Large-scale testing (Phase 3)Study completedNCT00834106
What this trial is testing

Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)

Who this might be right for
HPV Infections
Merck Sharp & Dohme LLC 3,006
Large-scale testing (Phase 3)Active Not RecruitingNCT05056402
What this trial is testing

An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 1,382
Large-scale testing (Phase 3)Study completedNCT01381575
What this trial is testing

Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,447
Not applicableUnknownNCT04969445
What this trial is testing

The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerVaginal Intraepithelial Neoplasia+2 more
Jun Zhang 647
Not applicableActive Not RecruitingNCT00867464
What this trial is testing

Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls

Who this might be right for
Anal CarcinomaCervical CarcinomaHuman Papillomavirus Infection+2 more
National Cancer Institute (NCI) 8,670
Testing effectiveness (Phase 2)UnknownNCT02710851
What this trial is testing

Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine

Who this might be right for
Condylomata Acuminata
Jun Zhang 640
Testing effectiveness (Phase 2)Study completedNCT00693966
What this trial is testing

Dose-Comparison Study to Evaluate the Safety and Immunogenicity of MEDI-517 (GSK 580299) in Healthy Adult Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 210
Not applicableActive Not RecruitingNCT06197802
What this trial is testing

Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 392
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06273553
What this trial is testing

A Study in Subjects With Human Papillomavirus 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3

Who this might be right for
Human Papillomavirus Associated Intraepithelial NeoplasiaCervical Intraepithelial Neoplasia Grade 2/3Human Papillomavirus Type 16 Infection+1 more
RinuaGene Biotechnology Co., Ltd. 39
Not applicableUnknownNCT01298869
What this trial is testing

The Study of Immunogenicity of Quadrivalent Vaccine Against Human Papilloma Virus (HPV) Types 6, 11, 16, and 18 (HPV-6/11/16/18) in Chronic Kidney Disease (CKD) Patients

Who this might be right for
Chronic Kidney Disease, Stage IV (Severe)Chronic Kidney Disease, Stage V
Chulalongkorn University 60
Testing effectiveness (Phase 2)Study completedNCT05694728
What this trial is testing

A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine

Who this might be right for
Human Papilloma Virus Infection
Beijing Health Guard Biotechnology, Inc 780
Not applicableStudy completedNCT01158209
What this trial is testing

An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus Types in Women in Egypt

Who this might be right for
Human Papillomavirus Infection
GlaxoSmithKline 490
Early research (Phase 1)Study completedNCT03085381
What this trial is testing

A Phase I Study of Quadrivalent HPV Recombinant Vaccine

Who this might be right for
HPV Infections
Shanghai Bovax Biotechnology Co., Ltd. 90
Load More Results